Reach Us +1-217-403-9671
Immunity, Immunotherapy And Immunomodulators ? Their Mechanism In Modifying Drug & Disease Response | 7387
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Immunity, immunotherapy and immunomodulators ? Their mechanism in modifying drug & disease response

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Anupama Koneru

ScientificTracks Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.002

Immunity refers to the resistance offered by an individual to the occurrence and spread of disease. It is a defensive mechanism developed to protect the body from invasion of foreign substances or pathogens and thus provide resistance. Immunotherapy is the treatment of disease by inducing, enhancing or suppressing an immune response. Immunomodulators modify immune responses and include a diverse array of recombinant, synthetic and natural preparations. Immunomodulators are classified as immunosuppressants (inhibit the immune response and are used in organ transplantations and autoimmune diseases, eg: cyclosporine, azathioprine prednisolone, muromonab CD3, etc.), immunostimulants (increase the immune response and are used in AIDS and cancers, eg: vaccines, cytokines, macokine, imiquimod, etc.) and tolerogens (induce tolerance and makes the tissue non-responsive to antigens, eg: recombinant fusion proten molecules, anti CD50 MAB, soluble HLA, etc). Thus immune systems can be modulated by different ways with the use of exogenous or endogenous bioactive agents which utilize cell-to-cell signaling in order to reach homeostasis within an organism?s innate cellular defences.
Anupama Koneru is the Vice-Principal of Sultan-ul-uloom College of Pharmacy, Hyderabad, Andhra Pradesh, India. She has an academic and administrative experience of over 15 years and is a university Gold medalist in her graduation. She has published 16 articles in various national and international peer reviewed journals and presented 18 papers in various conferences, viz., Indian Pharmaceutical Congresses, National Conferences of Association of Pharmacy Teachers of India (APTICON), National Conferences of Indian Pharmacological Society, National AYUSH Conferences, etc. She had received best paper presentation awards. She was also awarded ?Best power point Presentation by a Pharmacy Teacher? jointly by Association of Pharmacy Teachers of India and